Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 14,940
-730 (-4.66%)
Last updated: May 20, 2026, 2:25 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 940.26 billion as of May 19, 2026. Its market cap has increased by 55.61% in one year.
Market Cap
940.26B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,940.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 940.26B, an increase of 2,195.57%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 940.26B | 7.85% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hugel | 2.82T |
| D&D Pharmatech | 2.72T |
| Orum Therapeutics | 1.46T |
| Chabiotech | 1.38T |
| Onconic Therapeutics | 876.66B |
| GI Innovation | 819.03B |
| GC Corp. | 702.36B |
| Medy-Tox | 669.28B |